Experienced in Blepharitis

Dr. John A. Hovanesian

Ophthalmology
Laguna Hills, CA 
Accepting New Patients
Experienced in Blepharitis
Laguna Hills, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Hovanesian is an Ophthalmologist in Laguna Hills, California. Dr. Hovanesian is rated as an Experienced provider by MediFind in the treatment of Blepharitis. His top areas of expertise are Cataract, Pterygium, Astigmatism, Dry Eye Syndrome, and Cataract Removal. Dr. Hovanesian is currently accepting new patients.

His clinical research consists of co-authoring 47 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Blepharitis.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Laguna Hills, CA 92653

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Device
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Phase: Phase 3
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Device
Study Phase: Not Applicable
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
Enrollment Status: Completed
Publish Date: January 03, 2022
Intervention Type: Drug
Study Phase: Phase 4
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Device
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
Enrollment Status: Completed
Publish Date: March 12, 2021
Intervention Type: Drug
Study Phase: Phase 4
The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery
The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery
Enrollment Status: Completed
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
Patient-Reported Satisfaction and Spectacle Independence With the ReSTOR 2.5 Combined With the ReSTOR 3.0 IOL in Cataract Surgery
Patient-Reported Satisfaction and Spectacle Independence With the ReSTOR 2.5 Combined With the ReSTOR 3.0 IOL in Cataract Surgery
Enrollment Status: Completed
Publish Date: June 05, 2019
Intervention Type: Device
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Enrollment Status: Terminated
Publish Date: October 12, 2018
Intervention Type: Drug
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Enrollment Status: Completed
Publish Date: March 07, 2017
Intervention Type: Drug
Study Phase: Not Applicable
View 10 Less Clinical Trials

47 Total Publications

Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial.
Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: July 28, 2025
Similar Doctors
Distinguished in Blepharitis
Dr. Francis S. Mah
Ophthalmology
Distinguished in Blepharitis
Dr. Francis S. Mah
Ophthalmology

Scripps Health

9888 Genesee Ave, 
La Jolla, CA 
 (56.0 miles away)
858-626-4123
Languages Spoken:
English
See accepted insurances

Francis Mah is an Ophthalmologist in La Jolla, California. Dr. Mah is rated as a Distinguished provider by MediFind in the treatment of Blepharitis. His top areas of expertise are Blepharitis, Interstitial Keratitis, Cataract, Cataract Removal, and Corneal Transplant.

Distinguished in Blepharitis
Dr. Marjan Farid
Ophthalmology
Distinguished in Blepharitis
Dr. Marjan Farid
Ophthalmology

Regents Of The University Of California

101 The City Dr S, 
Orange, CA 
 (17.5 miles away)
714-456-8068
Languages Spoken:
English
See accepted insurances

Marjan Farid is an Ophthalmologist in Orange, California. Dr. Farid is rated as a Distinguished provider by MediFind in the treatment of Blepharitis. Her top areas of expertise are Astigmatism, Keratoconus, Hereditary Keratitis, Corneal Transplant, and Cataract Removal.

Distinguished in Blepharitis
Dr. David S. Michelson
Ophthalmology
Distinguished in Blepharitis
Dr. David S. Michelson
Ophthalmology
9834 Genesee Ave, Suite 200, 
La Jolla, CA 
 (56.0 miles away)
858-457-3050
Languages Spoken:
English
See accepted insurances

David Michelson is an Ophthalmologist in La Jolla, California. Dr. Michelson is rated as an Advanced provider by MediFind in the treatment of Blepharitis. His top areas of expertise are Blepharitis, Dry Eye Syndrome, Cataract, and Glaucoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hovanesian's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile